Warfarin treatment of a patient with coagulation factor IX propeptide mutation causing warfarin hypersensitivity.
D000595:Amino Acid Sequence; D019943:Amino Acid Substitution; D000925:Anticoagulants / Q000009:adverse effects*; D001241:Aspirin / Q000627:therapeutic use; D001483:Base Sequence; D004342:Drug Hypersensitivity / Q000235:genetics*; D005164:Factor IX / Q000235:genetics*; D019918:Heart Valve Prosthesis Implantation; D006801:Humans; D019934:International Normalized Ratio; D009154:Mutation; D010314:Partial Thromboplastin Time; D020641:Polymorphism, Single Nucleotide; D011498:Protein Precursors / Q000235:genetics; D014859:Warfarin / Q000009:adverse effects*
D000925:Anticoagulants; D011498:Protein Precursors; D014859:Warfarin; D005164:Factor IX; D001241:Aspirin